Aptamer applications in emerging viral diseases (2021)
Krüger, Arne 
; Santos, Ana Paula de Jesus ; Sá, Vanessa Karen de ; Ulrich, Henning ; Wrenger, Carsten
Source: Pharmaceuticals. Unidades: IQ, ICB
Subjects: PARASITOLOGIA, OLIGONUCLEOTÍDEOS, PEPTÍDEOS, VIROSES, COVID-19, VÍRUS DE DNA, VÍRUS DE RNA, MOLÉCULA, DNA VIRAL, RNA VIRAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KRÜGER, Arne et al. Aptamer applications in emerging viral diseases. Pharmaceuticals, v. 14, n. 7, p. 1-19, 2021Tradução . . Disponível em: https://doi.org/10.3390/ph14070622. Acesso em: 17 jun. 2024.APA
Krüger, A., Santos, A. P. de J., Sá, V. K. de, Ulrich, H., & Wrenger, C. (2021). Aptamer applications in emerging viral diseases. Pharmaceuticals, 14( 7), 1-19. doi:10.3390/ph14070622NLM
Krüger A, Santos AP de J, Sá VK de, Ulrich H, Wrenger C. Aptamer applications in emerging viral diseases [Internet]. Pharmaceuticals. 2021 ; 14( 7): 1-19.[citado 2024 jun. 17 ] Available from: https://doi.org/10.3390/ph14070622Vancouver
Krüger A, Santos AP de J, Sá VK de, Ulrich H, Wrenger C. Aptamer applications in emerging viral diseases [Internet]. Pharmaceuticals. 2021 ; 14( 7): 1-19.[citado 2024 jun. 17 ] Available from: https://doi.org/10.3390/ph14070622
